Completed OBSERVATIONAL NCT02909283

Sickle Cell Anemia and Cerebral Microcirculation : Multimodal Exploration (DREAM²)

Determinants of Cerebral Oxygenation and Perfusion in SCA Children Based on Combined ASL MRI, NIRS and Hemorheological Investigation

Sponsor: Hopital Universitaire Robert-Debre

Conditions Sickle Cell Disease

Interventions Physical exams and blood analyzes

Updated 12 times since 2017 Last updated: Nov 12, 2018 Started: Mar 2, 2015 Primary completion: Jul 11, 2017 Completion: Jul 11, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Sickle Cell Disease and is currently completed. Hopital Universitaire Robert-Debre leads this study, which shows 12 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

12 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jun 2022 — Jul 2024 [monthly]

Completed
Dec 2021 — Jun 2022 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed

▶ Show 7 earlier versions

Nov 2020 — Jan 2021 [monthly]

Completed
Dec 2018 — Nov 2020 [monthly]

Completed
Jun 2018 — Dec 2018 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hopital Universitaire Robert-Debre
Imagine Institute

Data source: Imagine Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Créteil, France
• Paris, France